Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 1
2018 1
2019 3
2020 6
2021 6
2022 8
2023 8
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

30 results

Results by year

Filters applied: . Clear all
Page 1
Natural History of Chronic Intestinal Pseudo-obstruction and Need for Palliative Care.
Tanaka K, Ohkubo H, Yamamoto A, Takahashi K, Kasai Y, Ozaki A, Iwaki M, Kobayashi T, Yoshihara T, Misawa N, Fuyuki A, Kato S, Higurashi T, Hosono K, Yoneda M, Kurihashi T, Taguri M, Nakajima A, Gwee KA, Kessoku T. Tanaka K, et al. Among authors: misawa n. J Neurogastroenterol Motil. 2023 Jul 30;29(3):378-387. doi: 10.5056/jnm22152. J Neurogastroenterol Motil. 2023. PMID: 37417265 Free PMC article.
Comparison of the diagnostic performance of NBI, Laser-BLI and LED-BLI: a randomized controlled noninferiority trial.
Higurashi T, Ashikari K, Tamura S, Takatsu T, Misawa N, Yoshihara T, Ninomiya Y, Okamoto Y, Taguri M, Sakamoto T, Oka S, Nakajima A, Tanaka S, Matsuda T. Higurashi T, et al. Among authors: misawa n. Surg Endosc. 2022 Oct;36(10):7577-7587. doi: 10.1007/s00464-022-09197-8. Epub 2022 Apr 11. Surg Endosc. 2022. PMID: 35411460 Free PMC article. Clinical Trial.
Leukotriene Receptor Antagonist Therapy for the Chemoprevention of Human Rectal Aberrant Crypt Foci: Nonrandomized, Open-Label, Controlled Trial.
Higurashi T, Ashikari K, Tamura S, Saigusa Y, Takatsu T, Misawa N, Yoshihara T, Matsuura T, Fuyuki A, Ohkubo H, Kessoku T, Hosono K, Yoneda M, Nakajima A. Higurashi T, et al. Among authors: misawa n. Cancer Prev Res (Phila). 2022 Oct 4;15(10):661-668. doi: 10.1158/1940-6207.CAPR-22-0049. Cancer Prev Res (Phila). 2022. PMID: 36083855 Clinical Trial.
Rationale and design of a multicentre, 12-week, randomised, double-blind, placebo-controlled, parallel-group, investigator-initiated trial to investigate the efficacy and safety of elobixibat for chronic constipation.
Tanaka K, Kessoku T, Yamamoto A, Takahashi K, Kasai Y, Ozaki A, Iwaki M, Kobayashi T, Yoshihara T, Misawa N, Kato T, Arimoto J, Fuyuki A, Sakai E, Higurashi T, Chiba H, Hosono K, Yoneda M, Iwasaki T, Kurihashi T, Nakatogawa M, Suzuki A, Taguri M, Oyamada S, Ariyoshi K, Kobayashi N, Ichikawa Y, Nakajima A. Tanaka K, et al. Among authors: misawa n. BMJ Open. 2022 May 30;12(5):e060704. doi: 10.1136/bmjopen-2021-060704. BMJ Open. 2022. PMID: 35636802 Free PMC article. Clinical Trial.
30 results